Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 108 Carcinoma, Non-Small-Cell Lung 95 Prostatic Neoplasms 58 Multiple Myeloma 45 Neoplasms 38 Neoplasm Metastasis 33 Ovarian Neoplasms 26 Melanoma 24 Urinary Bladder Neoplasms 23 Lung Neoplasms 22 Colorectal Neoplasms 22 Recurrence 21 Leukemia, Lymphocytic, Chronic, B-Cell 21 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Carcinoma, Renal Cell 20 Carcinoma, Hepatocellular 17 Triple Negative Breast Neoplasms 16 Nasopharyngeal Carcinoma 16 Lymphoma, Non-Hodgkin 16 Stomach Neoplasms 15 Leukemia, Myeloid, Acute 15 Lymphoma 14 Squamous Cell Carcinoma of Head and Neck 13 Small Cell Lung Carcinoma 13 Fallopian Tube Neoplasms 12 Colonic Neoplasms 12 Carcinoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Follicular 11

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × Lymphangioleiomyomatosis × Clear all

NCT03150914 2024-12-24

MILED

University of Cincinnati

Phase 3 Active not recruiting

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡